Study guide
25.2 Adverse Contrast Reactions (Mild, Moderate, Severe) & Emergency Treatment Protocols
Philippine Radiologic Technologists Licensure Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Subject 1, Chapter 1: Physics of Radiology & X-Ray Production
1.1 Atomic Structure, Electromagnetic Spectrum & X-Ray Production Mechanisms 1.2 X-Ray Tube Components, Target Interactions & Emission Spectrum 1.3 Photon Interactions with Matter: Photoelectric, Compton, Coherent & Pair Production
2 Subject 1, Chapter 2: Radiographic Equipment & Circuitry
2.1 High-Voltage Generators, Transformers & Rectification Circuits 2.2 Automatic Exposure Control (AEC), Beam Restriction & Quality Control 2.3 Tube Rating Charts, Extending Tube Life, Mechanical Malfunction & Preventive Maintenance
3 Subject 1, Chapter 3: Radiobiology & Cellular Response
3.1 Radiation Interaction with Tissue, Direct/Indirect Action & LET/RBE 3.2 Law of Bergonie & Tribondeau, Deterministic vs. Stochastic Effects 3.3 Dose-Response Relationships, Embryo and Fetal Effects & Acute Radiation Syndrome
4 Subject 1, Chapter 4: Radiation Protection & Dose Limits
4.1 ALARA Principles, Structural Shielding & Dose Limits 4.2 Personnel Dosimetry & Patient Dose Reduction Techniques 4.3 Dose Calculation Problems: Time, Distance, Shielding & Structural Barrier Design
5 Subject 1, Chapter 5: Imaging Informatics & Quality Assurance
5.1 PACS Architecture, DICOM Standards & HL7 Integration 5.2 Quality Assurance & Quality Control Protocols in Diagnostic Radiography 5.3 Radiology Workflow, RIS/HIS Integration, Teleradiology & Informatics Quality Assurance
6 Subject 2, Chapter 6: Film-Screen Radiography & Sensitometry
6.1 Film Emulsion, Latent Image Formation & Darkroom Chemistry 6.2 Sensitometric Curve (H&D Curve), Film Speed & Contrast Characteristics 6.3 Radiographic Film Analysis: Processing Faults, Handling Artifacts & Corrective Measures
7 Subject 2, Chapter 7: Technical Factors & Radiographic Quality
7.1 Density/Brightness, Contrast, Spatial Resolution & Distortion Controls 7.2 Exposure Math: Inverse Square Law, 15% Rule & Grid Conversion Factors 7.3 Technique Compensation: Age, Pathology, Cast and Orthopaedic Devices, Screen Speed & Beam Restriction
8 Subject 2, Chapter 8: Computed Radiography (CR)
8.1 Photostimulable Phosphor (PSP) Plates & CR Reader Mechanics 8.2 Image Processing, CR Artifacts & Erasure Protocols
9 Subject 2, Chapter 9: Digital Radiography (DR)
9.1 Flat-Panel Detectors: Direct vs. Indirect Conversion & TFT Arrays 9.2 Detective Quantum Efficiency (DQE), Modulation Transfer Function (MTF) & Dynamic Range
10 Subject 2, Chapter 10: Exposure Indicators & Image Evaluation
10.1 Exposure Indicators (S-Number, EI, DI), Windowing & Look-Up Tables (LUT) 10.2 Image Critique Checklist, Artifact Identification & Quality Control Standards 10.3 Image Display & Hard-Copy Output: Monitor Classification, DICOM GSDF, Dry vs Wet Laser Imaging
11 Subject 3, Chapter 11: Chest, Abdomen & Routine Positioning Concepts
11.1 Anatomical Terminology, Body Planes & Chest Radiography (PA, Lateral, Decubitus) 11.2 Abdominal Radiography: Acute Abdomen Series & Erect/Supine Protocols 11.3 Radiologic Surface Anatomy, Body Habitus & Sectional Body Cuts
12 Subject 3, Chapter 12: Upper & Lower Extremities & Girdles
12.1 Upper Limb & Shoulder Girdle Positioning (Hand, Wrist, Forearm, Elbow, Humerus, Shoulder) 12.2 Lower Limb & Pelvic Girdle Positioning (Foot, Ankle, Leg, Knee, Femur, Pelvis, Hip)
13 Subject 3, Chapter 13: Spine & Bony Thorax
13.1 Cervical, Thoracic & Lumbar Spine Radiography & Trauma Adaptations 13.2 Sacrum, Coccyx, Sacroiliac Joints & Bony Thorax (Ribs & Sternum)
14 Subject 3, Chapter 14: Cranium, Facial Bones & Paranasal Sinuses
14.1 Skull Positioning: Towne, Caldwell, Lateral & SMV Projections 14.2 Facial Bones, Orbits, Zygomatic Arches & Paranasal Sinuses
15 Subject 3, Chapter 15: Contrast Media Studies & Special Procedures
15.1 Gastrointestinal Contrast Procedures (Esophagram, UGI, Small Bowel, Barium Enema) 15.2 Genitourinary, Biliary & Special Fluoroscopic Studies (IVU, Cystography, ERCP, Myelography) 15.3 Reproductive System Studies: Hysterosalpingography, Pelvimetry & Male Reproductive Procedures 15.4 Nasopharyngography, Sialography & Fistulography / Sinus Tract Visualization
16 Subject 4, Chapter 16: Human Anatomy, Physiology & Pathology Integration
16.1 Body System Anatomy & Systemic Physiology Overview for Radiographers 16.2 Radiologic Pathology: Image Manifestations of Neoplastic, Inflammatory & Traumatic Conditions
17 Subject 4, Chapter 17: Patient Assessment, Communication & Informed Consent
17.1 Professional Communication, History Taking & Patient Rights 17.2 Informed Consent, Medical Documentation & Patient Transfer Safety
18 Subject 4, Chapter 18: Infection Control & Vital Signs Monitoring
18.1 Standard Precautions, Asepsis, Sterilization & Isolation Protocols 18.2 Measurement & Assessment of Vital Signs (BP, Pulse, Respiration, Temperature)
19 Subject 4, Chapter 19: Emergency Care & Aseptic Venipuncture
19.1 Basic Life Support (BLS), CPR Concepts & Emergency Response in Radiology 19.2 Aseptic Venipuncture Technique, IV Maintenance & Extravasation Care
20 Subject 4, Chapter 20: Professional Ethics, Jurisprudence & RA 7431
20.1 Republic Act No. 7431 (Radiologic Technology Act of 1992) & Board Rules 20.2 Code of Professional Ethics, Legal Liabilities, Malpractice & Negligence 20.3 Bioethical Principles in Practice, Professional Virtues & Interprofessional Relationships
21 Subject 5, Chapter 21: Diagnostic Ultrasonography
21.1 Ultrasound Physics, Transducer Construction & Doppler Principles 21.2 Acoustic Artifacts, Clinical Applications & Safety (TI/MI) 21.3 Clinical Ultrasound Examinations: Indications, Patient Preparation, Scanning Protocols & Transducer Selection
22 Subject 5, Chapter 22: Computed Tomography (CT)
22.1 CT Physics, Gantry Components, Detectors & Helical/Multislice Acquisition 22.2 Hounsfield Units, Windowing, CT Artifacts & Radiation Dose (CTDI/DLP)
23 Subject 5, Chapter 23: Magnetic Resonance Imaging (MRI)
23.1 MRI Physics, Nuclear Spin, T1/T2 Relaxation & Pulse Sequences 23.2 MRI Safety (Zones I-IV, SAR, Metallic Implants) & Common Artifacts 23.3 MRI Examination Protocols, Patient Preparation, Gadolinium Contrast & Sectional MRI Anatomy
24 Subject 5, Chapter 24: Interventional Radiology & Vascular Imaging
24.1 Vascular Access, Seldinger Technique & Digital Subtraction Angiography (DSA) 24.2 Interventional Procedures (Embolization, Angioplasty, Stenting) & C-Arm Radiation Safety 24.3 Interventional Patient Management: Contrast Selection, Pre-Procedure Workup & Post-Procedure Care
25 Subject 5, Chapter 25: Contrast Media Pharmacology & Adverse Reactions
25.1 Classification of Contrast Agents: Osmolality, Viscosity & Iodine Concentration 25.2 Adverse Contrast Reactions (Mild, Moderate, Severe) & Emergency Treatment Protocols 25.3 General Pharmacologic Principles: Pharmacokinetics, Pharmacodynamics, Drug Categories & the Rights of Drug Safety
26 Subject 5, Chapter 26: Nuclear Medicine & Molecular Imaging
26.1 Radioisotopes, Radiopharmaceuticals & Gamma Camera / SPECT Operation 26.2 Positron Emission Tomography (PET/CT) & Unsealed Radiation Source Safety
27 Subject 5, Chapter 27: Radiation Therapy & Radiation Oncology
27.1 Principles of Radiation Oncology, Linear Accelerators & Treatment Planning 27.2 Teletherapy vs. Brachytherapy, Patient Immobilization & Side Effect Management 27.3 Isodose Planning, Treatment Delivery Methods & Radiobiologic Principles in Radiation Therapy
28 Mammography & Dental Radiography
28.1 Mammography: Equipment, CC and MLO Positioning, Compression & Breast Pathology 28.2 Dental Radiography: Paralleling and Bisecting Techniques, Bitewing, Occlusal, Panoramic & Cephalometric
29 Medical Terminology for Radiologic Technology
29.1 Medical Word Building: Root Words, Combining Forms, Prefixes & Suffixes 29.2 Medical Terms in General Medicine, Abbreviations, Symbols & Critiquing Requests and Reports
30 Radiology Administration, Organization & Leadership
30.1 Organizational Structure, Staffing & Licensing Requirements of a Radiology Facility 30.2 Radiology Department Management: Job Descriptions, Duties, Leadership Styles & Entrepreneurial Skills
25.2 Adverse Contrast Reactions (Mild, Moderate, Severe) & Emergency Treatment Protocols
Key Takeaways Explain This Topic AI
Idiosyncratic (anaphylactoid) reactions are unpredictable, non-IgE mediated mast cell degranulation events independent of contrast dose, whereas non-idiosyncratic (chemotoxic) reactions are strictly dose-dependent and related to osmolality and chemical toxicity.
A documented prior adverse contrast reaction is the single greatest risk factor for future reactions, requiring a 13-hour corticosteroid (Prednisone 50 mg at 13h, 7h, 1h) and antihistamine premedication protocol for elective re-exposure.
Mild contrast reactions (warmth, metallic taste, nausea, isolated hives) require patient reassurance and vital sign monitoring, while moderate reactions (extensive hives, wheezing, facial edema) demand supplemental oxygen, IV fluids, and targeted medication.
Epinephrine 1:1,000 (1 mg/mL) IM administered at a dose of 0.3 mg into the lateral thigh is the first-line life-saving medication for severe bronchospasm, laryngeal edema, and anaphylactic shock.
Severe vasovagal reactions characterized by bradycardia (<50 bpm) and profound hypotension require Atropine Sulfate 0.6–1.0 mg IV push alongside rapid IV normal saline fluid boluses and immediate emergency code activation.
Last updated: August 2026
- 25.2 Adverse Contrast Reactions (Mild, Moderate, Severe) & Emergency Treatment Protocols
- Overview of Adverse Contrast Reactions
Intravascular administration of iodinated radiopaque contrast media (ROCM) carries an inherent risk of adverse clinical reactions. Although the widespread adoption of non-ionic Low-Osmolar Contrast Media (LOCM) and Isosmolar Contrast Media (IOCM) has reduced overall reaction rates from ∼ 12 % \sim 12\% ∼ 12% (with ionic HOCM) to less than 1.5 % 1.5\% 1.5% , unpredictable and severe life-threatening reactions continue to occur.
The radiologic technologist (RadTech) is often the first healthcare provider to recognize early clinical signs of an adverse contrast reaction. Immediate recognition, precise classification of severity, rapid notification of the radiologist, and swift execution of emergency medical protocols are critical competencies for patient survival.
Reaction Mechanisms: Idiosyncratic vs. Non-Idiosyncratic
Adverse contrast reactions are broadly categorized into two fundamental pathophysiological mechanisms: idiosyncratic (anaphylactoid) and non-idiosyncratic (chemotoxic) . +-------------------------------------------------------------------------+
- | CONTRAST REACTION MECHANISMS |
- +------------------------------------+------------------------------------+
- | IDIOSYNCRATIC (ANAPHYLACTOID) | NON-IDIOSYNCRATIC (CHEMOTOXIC) |
- | - Unpredictable & Independent of | - Dose & Concentration Dependent |
- | Dose or Concentration | - Direct Chemotoxicity & High |
- | - Mimics Type I IgE Anaphylaxis | Osmolality Effects |
- | - Direct Mast Cell / Basophil | - Hemodynamic Shifts & Organ |
- | Histamine Release | Toxicity |
- | - Examples: Hives, Bronchospasm, | - Examples: Warmth, Nausea, |
- | Laryngeal Edema, Shock | Bradycardia, CIN, Seizures |
- +------------------------------------+------------------------------------+
- 1. Idiosyncratic (Anaphylactoid / Pseudo-Allergic) Reactions
Pathophysiology : Idiosyncratic reactions mimic true Type I IgE-mediated immediate hypersensitivity reactions, but they do not depend on prior antigen sensitization or antibody formation. Contrast media directly trigger non-IgE degranulation of tissue mast cells and circulating basophils, releasing inflammatory mediators such as histamine , bradykinin , leukotrienes , and prostaglandins .
Key Feature : Completely unpredictable and independent of contrast dose, volume, or rate of injection. A minute test dose of 1 mL 1 \text{ mL} 1 mL can trigger fatal anaphylactic shock just as readily as a 100 mL 100 \text{ mL} 100 mL bolus.
Clinical Signs : Urticaria (hives), pruritus, angioedema, bronchospasm, laryngeal edema, and anaphylactic shock.
2. Non-Idiosyncratic (Chemotoxic / Physiological) Reactions
Pathophysiology : Non-idiosyncratic reactions are caused by the direct physical and chemical properties of the contrast agent, including high osmolality, chemical cytotoxicity, binding to plasma proteins, and ion imbalances (such as calcium chelation).
Key Feature : Strictly dose-dependent and concentration-dependent . The severity of symptoms increases directly with larger volumes, higher iodine concentrations, and rapid injection rates.
Clinical Signs : Sensation of intense warmth/flushing, metallic taste in the mouth, nausea, vomiting, vasovagal responses (bradycardia and hypotension), cardiac arrhythmias, contrast-induced nephropathy (CIN), and seizures resulting from blood-brain barrier disruption.
3. Patient Risk Factors & Pre-Medication Protocols
High-Risk Profiles :
History of prior adverse reaction to iodinated contrast ( single greatest risk factor , increasing reaction risk 5-fold).
History of severe asthma or active bronchospasm.
History of severe food or drug allergies (multiple severe allergies).
Underlying cardiac disease, dehydration, renal impairment, or extreme age.
Note : A history of seafood or shellfish allergy was historically thought to indicate contrast allergy; modern evidence proves there is no cross-reactivity between iodine/contrast and shellfish tropomyosin. Shellfish allergy merely reflects a general allergic predisposition.
Elective Pre-medication Protocol (ACR 13-Hour Regimen) :
When contrast administration is medically necessary in a patient with a documented prior anaphylactoid contrast reaction, elective premedication suppresses mast cell degranulation:
Oral Prednisone : 50 mg 50 \text{ mg} 50 mg PO given at 13 hours , 7 hours , and 1 hour prior to contrast administration.
Oral / IV Diphenhydramine (Benadryl) : 50 mg 50 \text{ mg} 50 mg PO or IV given 1 hour prior to contrast administration.
Accelerated Emergency Protocol (IV) : Methylprednisolone (Solu-Medrol) 40 mg 40 \text{ mg} 40 mg IV every 4 hours until contrast study, plus Diphenhydramine 50 mg 50 \text{ mg} 50 mg IV 1 hour prior (minimum 4-hour lead time).
Severity Classification of Adverse Contrast Reactions
Adverse reactions are classified into three severity levels: Mild , Moderate , and Severe . Prompt recognition of clinical signs is essential to prevent rapid progression from mild symptoms to life-threatening collapse.
1. Mild Contrast Reactions
Characteristics : Non-life-threatening, self-limiting, and resolve without permanent sequelae. Require reassurance and close observation.
Clinical Manifestations :
- Sensation of generalized body warmth or flushing
- Metallic taste in the mouth
- Mild nausea or isolated vomiting
- Localized mild urticaria (hives) or cutaneous pruritus (itchiness)
- Mild nasal congestion, sneezing, or throat clearing
- Mild lightheadedness or anxiety
- 2. Moderate Contrast Reactions
Characteristics : Non-life-threatening initially, but cause significant patient distress and require prompt medical evaluation, close monitoring, and targeted pharmacological intervention to prevent progression.
Clinical Manifestations :
- Widespread or diffuse urticaria (extensive hives) and intense pruritus
- Moderate bronchospasm, wheezing, or mild dyspnea
- Facial, periorbital, or tongue swelling (angioedema) without airway compromise
Tachycardia ( > 100 bpm > 100 \text{ bpm} > 100 bpm ) or sinus bradycardia ( < 60 bpm < 60 \text{ bpm} < 60 bpm ) with stable blood pressure
- Moderate hypotension ( S B P > 90 mmHg SBP > 90 \text{ mmHg} SBP > 90 mmHg but dropping)
- Severe or protracted vomiting
- 3. Severe Contrast Reactions
Characteristics : Potentially fatal, life-threatening emergency events that demand immediate emergency code activation (Code Blue / EMS) and aggressive resuscitation.
Clinical Manifestations :
- Severe bronchospasm, severe dyspnea, cyanosis, and hypoxia
- Laryngeal edema presenting as inspiratory stridor and progressive upper airway obstruction
Profound hypotension ( S B P < 80 mmHg SBP < 80 \text{ mmHg} SBP < 80 mmHg ) combined with tachycardia (anaphylactic shock)
Severe bradycardia ( < 50 bpm < 50 \text{ bpm} < 50 bpm ) combined with profound hypotension (severe vasovagal reaction)
- Unresponsiveness, loss of consciousness, convulsions/seizures
- Cardiac arrest or lethal ventricular arrhythmias
- Emergency Treatment Protocols & Pharmacological Interventions
Every radiologic facility must maintain a fully stocked emergency crash cart and oxygen delivery equipment in the imaging suite. The table below outlines the definitive step-by-step treatment protocols for each severity tier:
Severity Tier Clinical Signs & Symptoms Primary Mechanism Immediate Action & First-Line Interventions Definite Pharmacological Protocols
Mild Warmth, metallic taste, nausea, sneezing, localized hives ( < 5 <5 < 5 lesions). Chemotoxic / Mild Idiosyncratic Stop injection if ongoing; provide patient reassurance; continuously monitor vital signs (BP, pulse, SpO 2 \text{SpO}_2 SpO 2 ). No drug required for warmth/taste. For symptomatic hives: Diphenhydramine (Benadryl) 25 – 50 mg IV or IM .
Moderate Widespread hives, moderate wheezing/bronchospasm, facial edema, tachycardia. Moderate Idiosyncratic (Anaphylactoid) Call for radiologist/nurse assistance; maintain IV line; administer supplemental oxygen ( 6 – 10 L/min 6–10 \text{ L/min} 6–10 L/min via mask). For wheezing: Albuterol inhaler 2–3 puffs or nebulizer. For moderate hives/edema: Diphenhydramine 25–50 mg IV . For progressive bronchospasm: Epinephrine 1:1,000 (1 mg/mL) IM 0.3 mg .
Severe Severe bronchospasm, laryngeal stridor, profound hypotension ( S B P < 80 SBP<80 SBP < 80 ), shock, cardiac arrest. Severe Anaphylactoid / Severe Vasovagal / Cardiac CALL CODE BLUE / EMS IMMEDIATELY ; position patient supine (elevate legs if hypotensive); maintain airway; high-flow O 2 \text{O}_2 O 2 ( 10 – 15 L/min 10–15 \text{ L/min} 10–15 L/min ). First-line drug: Epinephrine 1:1,000 IM 0.3 mg into lateral thigh (vastus lateralis), repeat q5-15 min. For hypotension: IV Fluid Bolus (0.9% Saline 1–2 Liters) . For vagal bradycardia: Atropine 0.6–1.0 mg IV push . CPR if pulse absent.
- Detailed Emergency Drug Protocols
- 1. Epinephrine (Adrenaline) — The Primary Life-Saving Drug
Epinephrine is the absolute first-line pharmacological agent for severe anaphylactoid reactions, severe bronchospasm, laryngeal edema, and anaphylactic shock.
Mechanism : Stimulates α 1 \alpha_1 α 1 -adrenergic receptors (causing vasoconstriction to reverse profound hypotension and mucosal edema) and β 1 / β 2 \beta_1/\beta_2 β 1 / β 2 -adrenergic receptors (causing bronchodilation and increasing cardiac output).
Concentration & Route :
Intramuscular (IM) : Concentration 1:1,000 (1 mg/mL) . Administer 0.3 mg (0.3 mL) IM into the anterolateral mid-thigh ( vastus lateralis muscle). Preferred route for non-arrest anaphylaxis due to rapid absorption and safety. May repeat every 5 to 15 minutes.
Intravenous (IV) : Concentration 1:10,000 (0.1 mg/mL) . Used only during cardiac arrest or profound shock refractory to IM injections, administered as slow IV push ( 0.1 to 0.3 mg 0.1 \text{ to } 0.3 \text{ mg} 0.1 to 0.3 mg ) under continuous cardiac monitoring by a physician.
2. Atropine Sulfate — For Severe Bradycardia & Hypotension (Vasovagal Reaction)
Indication : Profound vasovagal reaction characterized by bradycardia ( < 50 bpm < 50 \text{ bpm} < 50 bpm ) accompanied by hypotension ( S B P < 90 mmHg SBP < 90 \text{ mmHg} SBP < 90 mmHg ) .
Mechanism : Parasympatholytic anticholinergic agent that blocks vagal nerve tone on the sinoatrial (SA) node, restoring normal heart rate.
Dosage & Route : 0.6 to 1.0 mg IV push , repeated every 3 to 5 minutes up to a maximum total dose of 3.0 mg ( 0.04 mg/kg 0.04 \text{ mg/kg} 0.04 mg/kg ).
3. Diphenhydramine (Benadryl) — Antihistamine
Indication : Symptomatic mild-to-moderate cutaneous allergic reactions (urticaria, pruritus, angioedema).
Mechanism : H 1 H_1 H 1 -receptor antagonist that blocks histamine binding sites.
Dosage & Route : 25 to 50 mg IV or IM (slow IV push over 1–2 minutes). Note: Diphenhydramine does not replace epinephrine in severe anaphylaxis or airway compromise.
4. Bronchodilators (Albuterol)
Indication : Isolated mild-to-moderate bronchospasm and wheezing with stable blood pressure.
Dosage & Route : Albuterol meter-dose inhaler (2 to 3 puffs) or 2.5 mg / 3 mL 2.5 \text{ mg} / 3 \text{ mL} 2.5 mg /3 mL nebulizer solution via oxygen mask.
5. Intravenous Fluids (Isotonic 0.9 % 0.9\% 0.9% Normal Saline)
Indication : Profound hypotension and distributive anaphylactic shock caused by systemic capillary leakage and vasodilation.
Administration : Rapid bolus infusion of 1 to 2 Liters 1 \text{ to } 2 \text{ Liters} 1 to 2 Liters of 0.9 % 0.9\% 0.9% Normal Saline or Ringer's Lactate under pressure.